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IDENTIFICATION AND CTIARACTERIZATION OF CELLULAR TARGETS OF
THE BACTERIAL CYTOTOXIN YOPT IN SACCHAROMYCES CEREVISIAE
Paul David Caccamo, M.S.
Western Michigan University, 2006
Human pathogenic Yersinia spp. utilize Type III Secretion to deliver six effector
proteins into host cells. The injected proteins resemble eukaryotic signal transduction
molecules and are capable of disrupting signaling pathways in order to subvert the
functions of the targeted cell or disrupt communication with surrounding cells. As a
result, bacterial invaders are not only able to survive the threat of a host immune
response, but can thrive despite it. YopT is a cysteine protease that cleaves RhoGTPases,
releasing them from the membrane and thus from their role as initiators of signaling
pathways, including the nucleation of actin and formation of stress fibers, filopodia, and
lamellipodia. This leads to disruption of the cytoskeleton, allowing pathogens to resist
phagocytosis by professional phagocytes.
This study employs the yeast Saccharomyces cerevisiae as a model system and
utilizes the techniques of yeast two-hybrid screening, generation of spontaneous mutant
suppressors of YopT lethality, and immunofluorescent microscopy to gain a better
understanding of the physical, molecular, and genetic basis of YopT lethality.
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I. Introduction
A. Human Pathogenic Yersinia spp.
The bacteria of the genus Yersinia are facultatively anaerobic, gram-negative rods
belonging to the family Enterobacteriaceae (23). The enterobacteria comprise one of the
most scientifically and medically significant groups of known microorganisms. Enteric
pathogens are responsible for the bulk of diarrhea and enteric fever that leads to more
than three million deaths annually, as well as opportunistic infections of
immunocompromised individuals (60, 110). In addition, many of the advances in
molecular and cellular microbiology have been driven largely by the study of these
bacterial pathogens, notably the model organism Escherichia coli.
Of the eleven known members of the genus Yersinia, three are pathogenic for
humans (187). Yersinia pestis is the causative agent of the plague, Yersinia
pseudotuberculosis causes mesenteric adenitis and septicemia, and Yersinia
enterocolitica, the most common in humans, causes a number of gastrointestinal
problems including acute enteritis and mesenteric lymphadenitis (54). While these three
species exhibit different degrees of virulence, all share an ability to multiply in lymphatic
tissues and to subvert the nonspecific immune response, in particular phagocytosis and
killing by macrophages and polymorphonuclear leukocytes (PMNs) (54, 86).
Despite a vast difference in pathogenesis, Y pestis and Y pseudotuberculosis are
closely related. Population genetic studies indicate that Y pestis is a recent clone of Y
pseudotuberculosis that is thought to have evolved over the last 1,500-20,000 years (3,
4). Conversely, Y. enterocolitica is thought to have long since diverged from Y
pseudotuberculosis (35, 139, 199). DNA-DNA hybridization and other biochemical
1

analyses show that Y pestis and Y pseudotuberculosis are nearly indistinguishable, and
genome comparisons show that three-quarters of predicted genes in Y
pseudotuberculosis have approximately 97% sequence homology in Y pestis (22, 49,
189).
Yet, consistent with its recent evolution, the Y pestis genome is one roiled by
genetic flux. At least 21 putative pathogenicity islands, large regions of non-native G+C
content that encode virulence genes, have been identified, including virulence
determinants, genes from insect pathogens, and novel surface proteins (156, 199). Y
pestis contains 140 insertion sequence (IS) elements, perfectly repeated sequences that
are likely sites of genomic rearrangement, which comprise 3.7% of the genome (199).
This is an unusually high number of IS elements, exceeding most described bacterial
genomes, and is approximately tenfold that of its ancestor Y pseudotuberculosis (156). In
addition, there is a high rate of gene loss. It contains approximately 150 psuedogenes,
most of which are found intact in the enteropathic Yersiniae (156).

B. Pathogenesis of Yersinia spp. Infections
Yersinia pestis
The plague, caused by Yersinia pestis, is predominantly a zoonotic disease of
rodents and other small mammals (74, 160). Often fatal in humans, its presence has been
felt throughout history. The first written record of the plague is thought to be an account
in the Bible, describing an outbreak among the Philistines in 1320 BCE.
[t]he Lord's hand was heavy upon the people of
Ashdod and its vicinity; he brought devastation
upon them and afflicted them with tumors. And
rats appeared in their land, and death and destruction
were throughout the city... [T]he Lord's hand
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was against that city, throwing it into a great panic.
He afflicted the people of the city, both young and
old, with an outbreak of tumors in the groin (1).
In modem times, there have been three major pandemics (with subsequent waves of
epidemics) among humans: the Justinian plague (sixth to eighth centuries), the Black
Death (fourteenth to seventeenth centuries), and the modem plague (1855 to present) (74,
160, 199).
The complex life cycle of plague involves mammalian reservoirs and a flea
vector, the classic example being the oriental rat fleaXenopsylla cheopsis. When a flea
feeds on an infected host animal, the ingested plague bacteria rapidly colonize the midgut
and spine-filled proventriculus. Colonization leads to blockage of the proventriculus,
effectively preventing the blood meal from reaching the stomach, causing the flea to
starve. As the ravenous flea attempts to feed, the consumed blood swells the esophagus
but cannot pass the blocked proventriculus. The flea is forced to relax its esophageal
muscles, vomiting Y pestis infected blood into the mammalian host (16, 74, 160).
Phagocytosis-resistant bacteria then spread to lymphatic tissue, where they proliferate.
The infected tissue becomes an inflamed and swollen "bubo" characteristic of the
bubonic plague. The bacteria are then spread via the blood stream to vital organs
(septicemic plague), rupturing blood vessels and causing internal bleeding. The
hemorrhaging lends the skin a dark color, hence the "Black Death". While it does not
require a flea vector for dissemination, the highly contagious pneumonic plague develops
if the infection reaches the lungs (160). Untreated, all forms of plague have a high
mortality rate.

3

In light of the genetic similarity between Y. pestis and Y. pseudotuberculosis, the
difference in pathogenicity is striking. It would appear that plasmid acquisition has
played a central role in the leap from an often self-limiting food-borne enteric pathogen
to a potentially fatal flea-transmitted systemic one. In addition to pYV, a Type III
Secretion (T3S) system encoding plasmid common to all human pathogenic Yersinia

spp., Y pestis contains two other plasmids. The plasmid pPla (also known as pPCPl and
pPST; 9 kb) encodes a plasminogen activator thought to aid in dissemination from the
site of the flea bite (38, 181). The plasmid pMTl (also known as pFra; 110 kb) encodes
the putative murine toxin Ymt as well as the F1 capsule, which inhibits phagocytosis (38,
61).
Plasmid acquisition is a striking difference between Y pestis and its less
pathogenic relatives. Less clear is the role that genomic downsizing has played in its
evolution. Genomic expansion via horizontal acquisition appears to be offset by genomic
decay, which occurs as a bacterium adapts to its host (199). Whole genome comparisons
between Y pestis and Y. pseudotuberculosis reveal a large number of psuedogenes and
missing sequences (so-called "black holes") (49, 133). Fully 13% of Y.

pseudotuberculosis genes are either missing or inactive in Y pestis (49). These reduction
events have been implicated in Y pestis adaptation to the flea host, the reduction of
unnecessary metabolic pathways, and increased virulence.
While often regarded as a disease of antiquity, the plague still poses a threat to
human health. Modern epidemics are still known to occur; between 1987 and 2001,
hundreds of cases were reported in at least 14 countries (198). In addition, the alarming
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discovery of multi-drug resistant strains and its potential for use as a biological weapon
illustrate the dangers still posed by this infamous organism (77, 106).

Yersinia pseudotuberculosis and Yersinia enterocolitica
Yersinia pseudotuberculosis and Yersinia enterocolitica are responsible for an
acute enteric infection known as yersinosis. Humans are.accidental hosts that become
infected by either direct contact with fecal matter of an infected animal or person or by
consuming food or drink contaminated with feces (180). Swine are the major reservoir of
human pathogenic forms and the disease occurs most commonly in regions with
temperate rather than tropical or subtropical climates, often during the winter months
(180).
Once ingested, the bacteria enter and attach to the lumen of the intestine. They
possess two different extracellular membrane (ECM) adhesins, invasin and YadA
(Yersinia adhesion A), that mediate attachment and uptake into host cells (64). lnvasin,
an outer membrane protein with a high affinity for p1 integrin receptors, is upregulated
upon entry into the gastrointestinal tract (108). The invasin-integrin interaction allows the
bacteria to enter the host cell, and the only cells to present p1 integrins to the lumen of
the small intestine are M cells located within the intestinal epithelium (50). Thus, M cells
serve as a portal for entry into the underlying lymphoid follicles of the Peyer's patches
(aggregates of intestinal lymphoid tissue) (15, 108). The bacteria multiply within the
Peyer's patches causing inflammation, tissue destruction, the sequestering of immune
cells, and subsequent dissemination to other tissues and organs, such as liver and spleen.
In order to overcome the host's immune response, mediated by PMNs and
macrophages, Yersinia spp. utilize a T3S system and the pYV encoded adhesin YadA
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(159). YadA proteins are lollipop-shaped surface projections, with a globular head, an
intermediate stalk and a C-terminal outer membrane anchor domain which form a
capsule-like structure on the bacterial surface (100). Upon migration to the Peyer's
patches, YadA becomes the primary adhesin expressed and is thought to enable the
intimate union between bacteria and host cell that is required for successful T3 S Yop
delivery (54, 64).
In most cases, infections by enteropathic Yersiniae are local and self-limiting.
Symptoms of yersinosis manifest themselves 3 to 7 days after infection and are
characterized by an assortment of gastrointestinal symptoms ranging from diarrhea,
abdominal pain, and fever to more severe mesenteric lymphadenitis lasting for 5 to 14
days (180). Possible post-infection symptoms include reactive polyarthritis, Reiters
syndrome, erythema nodosum, and glomerulonephritis (180).
While rare, yersinosis can develop into a systemic or septicemic disease. Even
with treatment, mortality is high and may include abscess formation in liver and spleen,
pneumonia, meningitis, septic arthritis and other severe symptoms (180). While bacterial
growth occurs in the extracellular environment of the Peyer' s patches, a recent review by
Pujol and Bliska examines evidence that all three pathogenic Yersinia can survive and
replicate within macrophage phagosomes (169). Macrophages may provide a protective
niche allowing for replication and eventual spread from the initial infection, resulting in
systemic infection.

C. Type III Secretion System
Bacteria employ a number of systems to manage the export of proteins either to
the cell surface or to the surrounding environment. A wide variety of gram-negative
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bacteria utilize the T3S system to target virulence effector proteins into host eukaryotic
cells (56,105,166). T3S systems were first identified in human pathogenic Yersinia spp.
when it was shown that secretion of proteins could be artificially induced in vitro at 37° C
+

and in the absence of Ca2 ions (136). Since the advent of genome sequencing,the
discovery of novel T3S systems has become a common occurrence,including organisms
with more than one. Subsequently,the list has grown to include the animal pathogens
Shigellaflexneri, Salmonella typhimurium, enteropathic Escherichia coli (EPEC),
Pseudomonas aeruginosa, Chlamydia spp. Bordetella spp.,Burkholderia spp.,
Citrobacter rodentium and Chromobacterium violaceum, plant pathogens Pseudomonas
syringae, Erwinia spp.,Ralstonia solanacearum, and Xanthomonas campestris, and
aquatic pathogens Aeromonas salmonicida, Aeromonas hydrophila, Vibrio
parahaemolyticus, Yersinia ruckeri, and Hahella chejuensis (14,31,36,42,72,76,88,
104,105,111,112,131,155,203).
A striking discovery to emerge from these analyses is that T3S systems are not the
sole province of pathogens,but are also found in commensals and symbionts (155).
Rhizobium spp. utilize the T3S system to aid in symbiosis with the root nodules of plants
(193). Photorhabdus luminescens, an endosymbiont of nematodes pathogenic to insects,
Sodalis glossinidius, an endosymbiont of the tsetse fly,and SZPE,the primary
endosymbiont of the grain weevil Sitophilus zeamais, all posses T3S systems (57,155).
UWE25,a symbiont of free-living amoebas related to Chlamydia, encodes a T3S system
(103). Many commensal,non-pathogenic E. coli strains also contain T3S systems (155).
Even more interesting is the discovery of full T3S systems in Desulfovibrio vulgaris, an
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environmental sulfate-reducing bacterium that has no known contact with eukaryotes
(95).
The T3S system may be more accurately described as a tool the bacteria uses to
initiate what J. E. Galan describes as "biochemical cross-talk" with its host (105). The
injected proteins often resemble eukaryotic signal transduction molecules and are capable
of disrupting or manipulating signaling pathways (105). Once these effector proteins are
translocated into the host eukaryotic cell, they act to subvert the functions of the targeted
cell or disrupt communication with surrounding cells (56). As a result, bacterial invaders
are not only able to survive the threat of a host immune response, but can thrive despite
it.
The genes encoding T3S systems are clustered together in functionally related
groups. These blocks of apparently foreign genes occur uniquely in pathogenic members
of a genus (135). Some pathogens possess unique virulence plasmids, while in others, the
gene clusters are located on the chromosomes in pathogenicity islands (105). These T3S
gene clusters were likely acquired throughout evolution by horizontal gene transfer, since
nonpathogenic relatives contain neither a virulence plasmid nor pathogenicity islands
(105). It is interesting to note that while the secretion apparatus itself is highly conserved
among a large range of bacterial organisms, the secreted proteins themselves are not.
Each organism uniquely tailors the ammunition to a common delivery system.

Similarity Between T3S and Flagellar Systems
One of the most striking revelations in the field is that T3S systems share genetic,
physical and functional similarity to the bacterial flagellar system. Comparisons of the
structural proteins encoded by various virulence T3S system have shown as many as 11
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conserved proteins, 10 of which exhibit sequence homology with components of the
flagellar export apparatus (105, 166). Other proteins show no sequence homology, but
related in function. When knocked out, they cause similar phenotypes in assembly or
function of the apparatus (30).
The flagellum consists of three main components: the basal body, the hook, and
the filament. The basal organization of the flagellar and T3S systems are similar, with a
hook and filament topping the flagellar basal body and a needle topping the T3S
structure. In addition to propulsion, the flagellum also serves as a sophisticated export
and self-assembly apparatus (130). The principal function of the flagellar secretion
apparatus is export of the extracellular components that make up the hook and filament.
The subunits are secreted through the lumen of the growing structure (114). When they
reach the distal end of the extending flagellum, a cap protein ensures proper
polymerization (201). This elongation process is recognized as a form of T3S, although it
is secondary to the motility function of the flagellum. In addition, both systems have been
shown to secrete the same proteins: phospholipase YplA in Yersinia and SptP in
Salmonella (124, 202).
The discovery of these remarkable similarities between the T3S and flagellar
systems has naturally led to consideration of the evolutionary relationship between them.
It has been proposed that T3S systems evolved from an early export system involved in
the assembly of flagella (75, 130, 150). This is not surprising, because flagella are ancient
structures and nigh ubiquitous among bacteria. Virulence T3S systems have been found
only in bacteria that have an intimate interaction with eukaryotic hosts, which evolved
more recently (93). However, recent analyses argue that there is no evidence that the
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virulence T3S arose from the flagellar apparatus and it is far more likely that they
diverged and evolved independently from a common ancestor (11,84).

D. Yersinia Type III Secretion
The earliest evidence of the T3S system in Yersinia spp. came from the induced
secretion of plasmid-encoded virulence proteins in vitro (94,136). An important
distinction must be made between the terms "secretion" and "translocation". Secretion
refers to the export of proteins from the bacterial cytoplasm to the extracellular milieu.
Translocation is the process of transporting proteins directly from the bacterial to the
eukaryotic cytosol. The delivery of proteins via the T3S system is polarized,meaning
there is a direct transfer from one cell to another with little leakage into the extracellular
space (162). While the capacity to secrete is necessary for the translocation of proteins,
they are functionally separate events (105). Thus,while not a true secretion apparatus in
the strictest sense of the word,the term is still used to describe it.
Pathogenicity in Yersiniae is associated with the presence of an approximately 70
kb virulence plasmid known as p YV,which encodes the components of a T3S system
(21,54,69, 80,81,206). These plasmids have been completely sequenced. Encoded
proteins include (i) Ysc (Yersinia secretion apparatus) proteins that form the secretion
machinery, (ii) Yop (Yersinia outer proteins) effector proteins that are delivered into the
eukaryotic host cell, (iii) proteins essential for attachment and/or translocation into host
cells,(iv) regulators of gene expression and Yop expression and secretion,and (v) Syc
(specific Yop chaperones) proteins which play a role in secretion and presecretory
stabilization of (ii) and (iii) (6,37,54,105,191). Ypestis contains two additional
plasmids that likely play a role in the plague's unique brand of pathogenicity (47).
10

Highlighting their close evolutionary relationship, transfer of the Y pestis virulence
plasmid into a plasmid-free avirulent strain of Y pseudotuberculosis strain confers
pathogenicity and the ability to produce Yops (197).
The genes encoding T3S systems tend to be clustered. While the Y enterocolitica
plasmid is structurally different from the related Y pestis/Y pseudotuberculosis plasmids,
the approximately 20 kb coding region of the secretion apparatus is highly conserved
among all three species (33, 105). The coding region of the highly conserved secretion
apparatus is divided into three operons: (i) yscA to yscL, (ii) yscN to yscU, and (iii) lcrD
(low calcium response) (105). Rounding out this 20 kb gene cluster are transcriptional
units that encode proteins responsible for transcription and secretion regulation: virF,
lcrR, lcrGVH, yopN, and lcrQ as well as translocator proteins YopB and YopD (105).

The Iniectisome
Bacteria that possess a T3S system translocate effector proteins into the host cell's
cytoplasm via a dedicated secretion apparatus. Electron microscopy studies of the related
T3S systems of Salmonella typhimurium, Yersinia enterocolitica, and Shigellaflexneri
reveal a morphology that is grossly similar to the flagellar hook-basal body complex and
topped by a stiff, hollow needle (51, 99, 120). The needles have an outer diameter of 6-7
nm, an inner diameter of approximately 2 nm, and are approximately 60 nm long (99,
113). The needle forms a helical structure and, in Yersinia, is constructed by the
polymerization of a 6 kDa protein subunit, YscF (51, 99, 113). The length of these
needles is genetically determined and is thought to have evolved specifically to span the
distance between bacterial and host cell surface structures when the two come into
contact (140).
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Needle length in Yersinia is determined by the protein YscP, which serves as a
molecular ruler (113). Knockout mutations of the yscP gene lead to needles of widely
varying length, and insertion/deletion mutations within yscP reveal a strict linear
relationship between the number of YscP residues and needle length (113). Further
highlighting the highly conserved nature of bacterial T3S and flagellar systems,
knockouts of the flagellar genefliK in Salmonella typhimurium, the T3S genes invJ in
Salmonella typhimurium, and the T3S gene spa32 in Shigellaflexneri yield similar
phenotypes of hooks or needles of indeterminate length (97, 121, 188).
YscP exhibits the lowest sequence similarity of any component among the highly
conserved T3S systems, at least at the primary sequence level. However, the C-terminus
of YscP contains a globular Type III secretion substrate specificity switch (T3S4)
domain. The overall structure of the globular T3S4 domain is highly conserved among
YscP orthologs and defines a unique family of proteins (8). As its name implies, this
domain is presumably involved in the switch from needle growth to effector secretion
when optimal needle length is reached (8). Thus, YscP serves a dual role: control of
needle length and control of Yop secretion. The current model postulates that the N- and
C-termini of YscP act as anchors, with one end attached to the growing tip of the needle
and the other attached to the basal body (113). When the appropriate length is reached,
the C-terminal T3S4 domain interacts with YscU of the basal body, prompting the switch
of substrate specificity from YscF to Yops (8, 63).

The Yersinia Translocon
Secretion of effector proteins in Yersinia via T3S results in the translocation of
cytotoxins directly into the cytoplasm of the target cell. Effectors are thought to cross the
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eukaryotic cell membrane via a transmembrane, pore-forming, channel complex known
as the translocon (43). The translocation system requires the proteins YopB, YopD, and
LcrV encoded on the lcrGVsycDyopBD operon (70, 90, 102, 149, 163). Both YopB and
YopD have clear hydrophobic domains that may result in membrane insertion and pore
formation (89). Supporting their proposed hydrophobic nature, YopB and YopD were
shown to insert in the membrane of erythrocytes and to form a pore in erythrocytes and in

nucleated cells (85, 91, 149). LcrV is necessary for pore formation, but has no obvious
hydrophobic domain and does not insert into the membranes of infected erythrocytes (85,
101). Since all three components have been shown to interact, LcrV is proposed to be the
hydrophilic core of a transmembrane channel that is stabilized by YopB and YopD (101,
141). In support of this, antibodies directed against LcrV can i) provide protection against
Yersinia pestis infections, ii) are able to block the translocation of effector proteins, and
iii) bind wild type needles tip to tip (96, 142, 163, 165). In addition, LcrV itself serves as
a virulence factor in Y pestis. LcrV acts to suppress the inflammatory response through
an unknown mechanism by upregulating the anti-inflammatory cytokine
IL-10 (39, 147).

Environmental and Genetic Regulation of T3S in Yersinia
Pathogenic bacteria utilize a variety of environmental cues to regulate virulence.
These cues often correspond to conditions encountered during infection of a host. In
Yersinia, gene expression is tightly regulated, most likely to avoid a toxic build-up of
effectors and to limit the energy intensive expression of the system. In vitro, this
regulation is known as the low calcium response (LCR), in which the T3S system is
+

expressed only at 37° C in the absence of Ca2 (105). Yop effector expression is
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suppressed at 26° C or at 37 ° C with Ca2 present. These two environmental conditions,
temperature and cation concentration, represent distinct regulatory events.
The shift in temperature from 26° C to 37 ° C positively regulates expression of the
T3S system. In Y enterocolitica, expression of these genes at 37 ° C is initiated by an
AraC-like transcriptional activator known as VirF (52). Thermoregulation of T3S
systems often depends on regulating access of nucleoid-associated proteins to target
DNA. At lower temperatures, the histone-like proteinYmoA suppresses transcription of

virF, thus suppressing transcription of the T3S system components (53, 55). At 37 ° C,
intrinsic bends in the pYV plasmid melt, altering the architecture of the plasmid and
presumably exposing the virF promoter, which corresponds with VirF production and
subsequent T3S gene expression (52, 55, 123, 170).
The expression of T3S genes are also regulated by the presence or absence of
divalent cations. In Yersinia spp., Ca2+ ion concentration regulates a negative feedback
+

mechanism that repressesYop production when Ca2 concentration is high. The proteins
LcrQ in Y.pseudotuberculosis and its homologsYscM1/YscM2 in Y enterocolitica
control gene expression at the transcriptional level (44, 45, 137, 164, 185). A current
model proposed by Carbonne and Schneewind suggests the formation of a protein
complex composed ofYopD, LcrH,YscMl , andYscM2 that binds the 5' untranslated
region (UTR) of yop mRNA (45). This complex may prevent translation and possibly
target mRNAs for degradation (12, 45). Environmental signals, including the presence of
glutamate and serum albumin and the absence of ca2+, cause the inactivation or secretion
of the complex subunits, allowing for translation ofYops to occur (45, 125). The LCR
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has only been demonstrated in vitro. This phenomenon appears to mimic the known in
vivo trigger of Yop expression, bacterial contact with the host cell (164).

Chaperones
Molecular chaperones are proteins that transiently bind to nascent or unfolded
polypeptides in order to prevent inopportune or inappropriate intra- or intermolecular
interactions. The T3S system is tightly regulated and as a result, some proteins are stored
in the bacterial cytoplasm before they are secreted. For some of these proteins, this
necessitates the presence of specific chaperones.
T3S chaperones have been provisionally divided into several classes based on the
role of the substrate (154, 157). Class I chaperones associate with effector proteins and
are further subdivided depending on if they are specific for a particular effector (Class
IA) or if they are promiscuous and associate with multiple effectors (Class IB). Class II
chaperones act in union with translocator proteins. Class III refers to flagellar chaperones.
Despite a wide diversity at the sequence level, T3S chaperones share a number of
common features. These chaperones are small (15 to 20 kDa), acidic (pl around 4.5)
proteins with a predicted C-terminal a-helix region, and are ATP-independent (105).
Those chaperones that exhibit specificity are often found in bicistronic operons with their
cognate substrate. In Yersinia, Yop-chaperone pairs include YopO-SycO, YopH-SycH,
YopE-YerA/SycE, YopT-SycT, YopN-SycN, YopD-LcrH/SycD and YopB-LcrH/SycD
(105, 127).
T3S chaperones are thought to play a variety of roles in type III secretion. The
highly regulated nature of the T3S system requires that proteins be maintained in the
cytoplasm. They must be stabilized, isolated from unwanted interactions, and maintained
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in a secretion competent state. Class I (effector) chaperones may involved in several of
these roles and appear to play regulatory functions in the TTS pathway (46, 154, 157).
Class II (translocator) and III (flagellar) chaperones are likely focused on preventing
premature interactions (154).
While experimental data is inconclusive, recent research hints at a hierarchical
component to secretion (24, 34, 44, 125, 129, 200). In Yersinia, translocator Yops (YopB
and YopD) as well as effector Yops with antiphagocytic functions (YopO, YopE, YopH,
and YopT) all have chaperones, while those that lack chaperones usually modulate more
gradual host responses, such as inflammation or apoptosis (YopM and YopP/J). As it
takes less than a minute for a macrophage to phagocytize a bacterium, it would be
advantageous for those expressing a T3S system establish a pore and translocate
antiphagocytic effectors in order to survive the initial onslaught, while saving
immunomodulatory functions for later.

E. Virulence Factors
The T3S system is utilized to deliver bacterial proteins into eukaryotic cells.
Inside host cells, these effectors engage in a variety of biochemical and cellular processes
usually limited to eukaryotes, resulting in subversion of host cellular activity to the
benefit of the bacteria. The injected proteins often resemble eukaryotic proteins in
sequence, structure, or function.
In Yersinia spp., these have been designated Yersinia outer proteins, or Yops. This
classification is the result of these proteins originally being identified in outer membrane
preparations of Y enterocolitica and Y pseudotuberculosis (167, 186). In addition to the
T3S apparatus, the Yops themselves are encoded on the 70 kb virulence plasmid, pYV.
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Upon contact with the host cell, Yersiniae translocate six effector proteins named YopH,
YopO/YpkA, YopP/YopJ, YopE, YopM, and YopT, via the type III secretion system.

YopH
Among the best characterized of the Yersinia effectors, YopH is a highly potent
phosphotyrosine phosphatase (PTP) (87). It has been described as the most active PTP
known and is an essential virulence determinant that inhibits macrophage phagocytosis
(33, 87,205). It is a 51 kDa, 468 amino acid protein with well defined N- and C-terminal
domains coupled to a proline rich center (191). Localized in the C-terminal region is a
catalytic domain similar to eukaryotic PTP catalytic domain and the N-terminus contains
T3S secretory signals, the SycH chaperone binding region, and a substrate binding
domain that targets tyrosine phosphorylated proteins (87, 117, 184, 196). Highlighting
the potency of these PTPs, late infection YopH activity leads to an almost complete
dephosphorylation of all substrate proteins within host cells (67).
YopH targeting is aimed at subverting pathways involved in phagocytosis of the
bacteria and related responses, such as the oxidative burst in macrophages and
+

neutrophils and Ca2 signaling involved in granulation (68, 191). YopH activity in host
cells is rapid, dephosphorylating phosphotyrosine proteins less than 30 s after infection
and exhibiting detectable association with substrates within 2 min (13,28,29, 161). This
quick response is critical in counteracting the equally rapid process of phagocytosis. A
substrate-trapping mutant was used to identify YopH targets. A point mutation of an
essential catalytic cysteine (C403A/S) completely abrogates PTP activity while retaining
substrate binding (13). Identified proteins include Cas (Crk-associated substrate), FAK
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(Focal adhesion kinase), FYB (Fyn-binding protein), and SKAP55-HOM (Src-kinase
associated protein of55 kDa homologue) (25, 27, 92, 161).

YopO/YpkA
YopO (Ypk.A in Y pseudotuberculosis) is an 80 kDa, ~730 amino acid
serine/threonine kinase with multiple functional domains. The first is a secretion domain
is located at the N-terminus (aa 1-77) (5, 191). Following the secretion domain is a
catalytic kinase domain (aa 150-400) that bears similarity to eukaryotic serine/threonine
kinases (78). In vitro, actin serves as both an activator and substrate for YopO/Ypk.A
kinase activity (115). Once activated, the catalytic domain autophosphorylates and is able
to phosphorylate other substrates, including actin (115). In vivo, however, actin may not
be the only cellular activator ofYopO/Ypk.A. HeLa cell cytosolic extracts and fetal calf
serum are sufficient to induce YopO/Ypk.A activity with no actin present (62). A new
substrate was recently discovered; otubain 1, a member ofthe family ofovarian tumor
(OTU)-like cysteine proteases involved in the ubiquitin pathway and interacts with the
actin cytoskeleton (19, 116).
The C-terminal half (aa 436-710) contains four regions with homology to Rho
binding domains (RBDs) (62). YopO/Ypk.A binds to Rho and Rae but not Cdc42 (20,
62). Binding affinity is similar regardless ofGDP- or GTP-bound state and does not
influence GDP/GTP exchange by the GTPase (191).The final 21 C-terminal amino acids
(aa 709-729) exhibit homology with the actin binding protein coronin (62, 115). Deletion
ofthese C-terminal amino acids eliminates actin binding and actin triggered
autophosphorylation (115).
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YopP/YopJ
YopP in Y enterocolitica (also known as YopJ) is a 33 kDa, 468 amino acid
protein that serves to disrupt signaling pathways involved in the immune response and
cell death when translocated into host cells (151, 191). It belongs to the CE clan of
cysteine proteases that disrupt posttranslational ubiquitin or ubiquitin-like modifications
on target proteins (151, 153). YopP/YopJ induces macrophage apoptosis and suppresses
production of pro-inflammatory cytokines such as TNF-a and IL-8 by blocking the
MAPK (mitogen-activated protein kinase) and NFKB (nuclear factor-KB) pathways (59,
138, 152, 171, 175). A recent study shows that YopP/YopJ acts as an acetyltransferase
that utilizes acetyl-CoA to block critical residues ofupstream kinases, preventing
phosphorylation (143).
Inhibition ofthese pathways is achieved by interdiction ofthe upstream kinase
components. In MAPK cascades, immediately upstream ofthe MAP kinase is a member
ofthe MAP kinase kinase (also known as MEK or MKK) family (158). YopP/YopJ
blocks phosphorylation and activation ofMEKs and thereby inhibits ERKs (extracellular
signal-regulated kinase), JNK/SAPKs (c-Jun NH2-terminal kinase/stress-activated
protein kinases), p38 MAP kinases, and other signaling pathways (152, 158). Normally,
NFKB is sustained in an inactive cytoplasmic state by IKBa. When IKBa is
phosphorylated by the �-subunit ofIKK (IKB kinase) it is targeted for degradation, thus
liberating NFKB to activate transcription ofgenes involved in the inflammatory response
and cell survival (192). YopP/YopJ prevents ubiquination ofIKK�, effectively shutting
down NFKB pathways (48).
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YopE
YopE is a 25 kDa, 219 amino acid protein that exhibits GAP (GTPase activating
protein) activity toward the Rho family GTPases, inactivating Rho, Rae, and Cdc42 in
vitro (9, 26, 195). GAPs act to downregulate GTPases by stimulating the conversion of
the active GTP-bound form of the GTPase to the inactive GDP-bound form. Located at
the N-terminus are regions necessary for secretion and translocation, as well as stable
complex formation and efficient secretion by the chaperone YerA/SycE (174, 184, 196).
The first 15 N-terminal residues are sufficient as a Yersinia T3S signal, not only for
YopE but for fusion reporter genes and Yop homolog constructs (34, 40). The seat of
GAP activity is situated C-terminally at residues 96-219, the mechanism of which is
conserved (5, 195). All GAP proteins contain an arginine finger motif which is required
and essential for GAP activity (66, 173). The arginine residue Arg-144 completes the
RhoGTPase active site, mimicking native GAP activity to rapidly stimulate intrinsic GTP
hydrolysis (73). YopE thus inactivates RhoGTPases, leading to disruption of the actin
cytoskeleton and subsequent cell rounding and cytotoxicity.
Recent studies suggest that YopE may have additional functions. In mammalian
cells, YopE localizes to the perinuclear membrane via a hydrophobic membrane
localization domain located in the chaperone binding region (119). This may suggest a
role in vesicle transport. YopE mutants lacking in vitro GAP activity were still able to
induce cytotoxicity (10). Cells that produced constitutively active RhoA were protected
from YopE-mediated disruption of actin filaments and cell rounding (26).
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YopM
Of the six known Yersinia effector proteins, YopM is the only one for which a
known target or catalytic activity has yet to be identified. YopM has been shown to be
necessary for full virulence in the mouse infection model (128). It is a highly acidic
protein belonging to the leucine-rich repeat (LRR) structural family of proteins (41, 118).
The number of repeats, and thus the size of the YopM protein, varies depending on the
Yersinia strain in which it is found (32, 190). Such variability is unusual, as T3S effector
proteins are often highly conserved, not only within Yersinia but also across species. The
YopM monomer is a horseshoe-like structure, which stacks to form a cylindrical tetramer
with an inner diameter of 35 A (65). YopM is ferried to the nucleus via a vesicular
trafficking system (179).
Structurally, its LRR motifs echo eukaryotic transcription factors. In addition, the
fact that it is trafficked to the nucleus raises the possibility that YopM acts as a
transcriptional modulator. To investigate YopM's effect upon transcriptional regulation,
microarray analyses of Y enterocolitica infected macrophages cell lines have been
performed (98, 172). Experimental results, however, remain inconclusive; one group
found evidence for regulation of genes concerned with cell cycle and cell growth with the
other finding no evidence for regulation at all (98, 172). YopM has also been shown to
interact with and activate two intracellular kinases, protein kinase C-like 2 (PRK.2) and
ribosomal S6 protein kinase 1 (RSKl) (134). Despite these studies, the precise cellular
function of YopM has yet to be elucidated.
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YopT
YopT is a 35 kDa, 322 amino acid protein that belongs to the CA clan and defines
the C58 family of cysteine proteases (176). It is expressed in Y pestis, Y enterocolitica
and in some Y pseudotuberculosis strains (5). It was the last of the effector Yops to be
discovered, likely because the Y pseudotuberculosis serotype 0:3 strain that is
commonly used for Yersinia research does not express it (191). Sequence comparisons
reveal at least 19 homologous open reading frames from a variety of microorganisms. In
addition to the three pathogenic Yersinia spp., other proposed members of the C58
cysteine protease family include the plant pathogen Pseudomonas syringae (AvrPphB),
plant symbionts Bradyrhizobium japonicum (Q89T99 and Q9AMW4) and Rhizobium
spp. (Y4zC), animal pathogens Escherichia coli O157:H7 (Efal and ToxB),
Haemophilus somnus (Q06277), Pasteurella multocida (PfhB1 and PfhB2), and
Haemophilus ducreyi (LspAl and LspA2), the insect pathogen Photorhabdus
luminescens (LopT), and the marine microorganism Hahella chejuensis (2, 5, 40, 112,
176). YopT family members can be divided into two groups. The first group, which
includes YopT, consists of proteins ~30-40 kDa that have been shown or are predicted to
be secreted by T3S systems (5, 176). The second group consists of proteins >300 kDa
which harbor additional functional domains (5, 176). While proposed sequences of these
putative cysteine proteases diverge widely, all have in common an invariant Cys/His/Asp
catalytic triad.
RhoGTPases undergo ordered posttranslational modifications at their C-terminal
CaaX box (C, cysteine; a, aliphatic residue; X, any residue) in which the C-terminal
cysteine is prenylated, the -aaX motif is removed, and the cysteine is carboxylmethylated
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(73,204). This modification allows for membrane anchorage of the GTPases. In vitro,
YopT cleaves RhoA,Rael ,and Cdc42 immediately N-terminally of the prenylated C
terminal cysteine (177). In vivo, YopT preferentially cleaves RhoA (5). Cleavage releases
the GTPase from the membrane,thus inactivating it (176,177). As with YopE,YopT
expression in cultured cells leads to disruption of the actin cytoskeleton and subsequent
cell rounding and cytotoxicity (107).
Catalytic activity is contingent on the invariant C/H/D residues C139,H258,and
D274 (176). Substrate specificity is determined by the presence of an isoprenoid lipid
modification and a sequence of basic amino acids at the C-terminal ofRhoGTPases
(177). YopT requires the isoprenoid group for binding and activity,but does not
discriminate between geranylgeranylated and farnesylated RhoA (177). In addition,
catalytic activity is similar regardless of GDP- or GTP-bound state ofRhoA (177).
Structural analysis of the YopT protein shows catalytic activity is chiefly located at the
C-terminus, while RhoGTPase binding is located at the N-terminus (183).

II. Research Goals
YopT was the last of the effector Yops to be discovered. Additionally, sequence
comparisons reveal at least 19 homologous open reading frames from a variety of
microorganisms. YopT family members can be divided into two groups: a first group,
which includes YopT,that consists of proteins ~30-40 kDa shown predicted to be
secreted by T3S systems and a second group that consists of proteins >300 kDa which
harbor additional functional domains. While there are well-defined in vivo and in vitro
targets of the Yersinia effector protein YopT,we feel that further examination of potential
YopT targets,and the processes that they affect,is warranted.
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We chose the yeast Saccharornyces cerevisiae as a model system to investigate
the cellular function of the bacterial cytotoxin YopT. Yeast is an ideal system with which
to investigate cell architecture and fundamental cellular mechanisms. S. cerevisiae has
several advantages among eukaryotic model systems. It is unicellular and can be grown
quickly on various selective media. Genetic techniques and functions have been well
defined in yeast. Cellular processes are highly conserved from yeast to mammals and
corresponding genes can often complement each other. Finally, the entire yeast genome
has been sequenced.
A number of different techniques were employed to identify and characterize
cellular targets ofYopT. The yeast two-hybrid system was used to attempt to identify
protein-protein interactions and thus identify potential cellular targets ofYopT. We
generated spontaneous mutant suppressors ofYopT induced lethality to gain a better
understanding of the genetic basis ofYopT action. Finally, we used immunofluorescent
microscopy to examine both YopT localization and the physical effect of its activity in
yeast cells.
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III. Materials and Method
Media
LB (Luria-Bertani) bacterial growth media has been previously described (132).
Yeast media YPD, S-ura, S-leu, S-ura-leu, S-trp, S-trp-leu, S-trp-leu-his, S-trp-leu-ade,
SD-ura, SD-leu, SD-ura-leu, SD-trp, SD-trp-leu, SD-trp-leu-his, SD-trp-leu-ade, Sgal-ura
and Sgal-ura-leu have been previously described (178).

Plasmids
Plasmid
pLN2

Bacterial Markers

Yeast Markers

2µ TRPl CYH2 PADH-GAL4(1-147)

pJG487
pPCI
YL2H-CI
YL2H-C2
YL2H-C3
pACTII

2µ TRPl CYH2 PADH-GAL4(l-147)-YopT
2µ LEU2 PADH1-GAL4 AD-TADHl
2µ LEU2 PADH1-GAL4 AD-TADHl
2µ LEU2 PADH1-GAL4 AD-TADHl
LEU2 2µ PADH1-GAL4 AD-TADHl

K

Reference

Cm ccdB attRl attR2
bla
fl KmK attLl attL2 YopT

This study

attB I attB2 bla

This study
(109)
(109)

bla

This study

(109)
(126)

pCRII
Blunt
TOPO
pPC2
pLN l l
pJG531
pJG532

LEU2 2µ PADH1-GAL4 AD-RHOI-TADHl

bla

This study

LEU2 2µ PADH1-GAL4 AD-RHO2-TADHl
LEU2 2µ PADH1-RHO3-GAL4 AD-TADHl
LEU2 2µ PADHI-RHO4-GAL4 AD-TADHI

bla
bla
bla

This study
This study
This study

pJG534
pJG533

LEU2 2µ PADH1-RHO5-GAL4 AD-TADHl
LEU2 2µ PADH1-CDC42-GAL4 AD-TADHl

bla
bla

This study
This study

pJG485

CEN6 ARSH4 URA3 PGAL1-V5-6HCYClterm
CEN6 ARSH4 LEU2 PGALl-YopT-V5-6HCYC!term
CEN6 ARSH4 URA3 PGALI-YopT-V5-6HCYClterm
CEN6 ARSH4 URA3 PGALl-YopE-V5-6HCYClterm
CEN6 ARSH4 URA3 PGALl-YopO-V5-6HCYClterm

bla fl attRI attR2 CmK
ccdB
bla fl attBl attB2

This study
This study

bla fl attB1 attB2

This study

bla fl attB1 attB2

This study

bla fl attB1 attB2

This study

pJG494
pJG495
pJG491
pLN5

lnvitrogen
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Yeast Strains
Strain

Description

Reference

JGY80

MA Ta his3-200 leu2-3, 112 trp1-901 ura3-52 ga/4 ga/80
LYS2::GAL1-HIS3 GAL2-ADE2 met2::GAL7-lacZ
MATa/MATx ade2-101/ADE2 LYS2/lys2-801 his3-200/his3-200
leu2-3, 112/leu2-3, 112 ura3-52/ura3-52

This study

JGY709

This study

Lithium Acetate Yeast Transformation
Transformation of each yeast strain was performed essentially as described by
Gietz and Schiestl (82).

GuHCI Yeast Genomic DNA Preparation
Cultures were inoculated from a single colony in 5 mls of appropriate media in a
sterile 15 ml tube and grown at 30° C, with shaking, overnight. Cultures were pelleted for
5 min in an Eppendorf 5810 R centrifuge at 2000 rpm. Supernatant was poured off; cells
were resuspended in 1 ml H20 and transferred to a 1.5 ml microfuge tube. Samples were
then spun down, the supernatant was removed by aspiration, and resuspended in 150 µl
SCE (1 M Sorbitol, 0.1 M Sodium Citrate, 0.01 M EDTA, adjust pH to 5.8). 1 µl B
MercaptoEthanol and 3 µl Zymolyase were added and samples were incubated at 37° C
for 1 h.
Next, samples were spun in a Labnet Spectrafuge 16M Microcentrifuge at 14000
rpm for 2 s, supernatant was carefully removed by aspiration, and resuspended slowly by
tritration in 150 µl GuHCl (4.5 M GuHCl, 0.1 M EDTA, 0.15 M NaCl, 0.05% Sarkosyl,
Adjust pH to 8.0). Samples were incubated at 70° C for 10 min and allowed to cool at
room temperature for 5 min. 150 µl of ice cold 100% ethanol was added and the sample
was mixed by vortexing. They were then spun down at 14000 rpm for 5 min in a
microcentrifuge. Supernatant was carefully removed using a micropipette and samples
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were allowed to dry with cap open on the bench for 10 min. After drying, they were
resuspended in 300 µl 1Ox TE (pH 8.0) and 500 µl Phenol/Chloroform/lAA (Sigma
Aldrich Co.) was added to each tube. They were vortexed to mix and spun down in a
microfuge at 14000 rpm for 5 min. Supernatant was transferred to a fresh, sterile
microfuge tube. To this was added 1/10 volume 3M NaOAc (pH 5.2) and two volumes
100% Ethanol. Solution was mixed thoroughly by inverting the tube 3-4 times and
allowed to precipitate overnight at -20° C.
DNA was pelleted in a 4° C cold room in a microcentrifuge at 14000 rpm for 10
min. Supernatant was carefully removed via aspiration. DNA was allowed to dry with
cap open at 37° C. DNA was resuspended in 300 µl H20 if being used for PCR or 50 µl
H20 for all other uses.

Titer Assay of YopT Lethality
YopT expression vector pJG495 and empty vector control pJG485 were initially
transformed into JGY709 wild type yeast. Transformants to be assayed were propagated
in S-ura medium containing 2% raffinose. Cultures were grown to saturation, diluted in
fresh raffinose containing medium, and grown to mid-log phase. Upon reaching the
appropriate turbidity (~60 Klett), YopT expression was induced by adding 2% galactose
directly to the culture.
For each sample and time point, turbidity of the culture was recorded and a 1 ml
aliquot was transferred to a 1.5 ml microfuge tube. Samples were then sonicated with a
FisherModel 50 Sonic Dismembrator at 3.5 W for 10 s to disperse clumps and separate
cyto-kinesed buds. A ten-fold serial dilution was performed and 100 µl of each dilution
was plated on SD-ura. These were allowed to grow at room temperature for
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approximately one week. The number of colony forming units per ml (cfu/ml) was
determined based upon dilution and colony count.

Generation of Suppressor Strains
Diploid yeast strain JGY709 was sequentially transformed with two YopT
expressing plasmids containing unique auxotrophic markers pJG495 (URA3) and pJG494
(LEU2). Individual colonies of pJG494/495 containing yeast were grown in S-ura-leu
liquid media containing 2% raffinose. Samples containing ~ 108 cells were plated on
S-ura-leu solid media containing 2% galactose to induce YopT expression. Colonies that
grew despite YopT induction were streaked on S-ura-leu solid media containing 2%
glucose. Streaks of pJG494/495 containing yeast were grown in S-ura-leu liquid media
containing 2% raffinose. Samples were then replica plated on YPD, SD-ura-leu, and
Sgal-ura-leu. Yeast that grew on all three were assumed to contain both plasmids and
survive YopT lethality.
Potential suppressor strains were streaked on YPD plates to obtain single
colonies. Single colonies were then replica plated on YPD, SD-ura, and SD-leu. Samples
that grew only on YPD were assumed to have lost both plasmids. These were then
retransformed with one of the YopT expressing plasmids to confirm suppressor
phenotype. Confirmed suppressors were then transformed with YopO and YopE
expressing plasmids to test specificity of suppression.

Actin Localization
1 ml aliquots of relevant samples and time points were transferred to 1.5 ml
microfuge tubes. Cells were fixed in 100 µl 37% formaldehyde (3. 7% final
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concentration) for 2 h at room temperature. Cells were pelleted at 3000 rpm in a Labnet
Spectrafuge 16M Microcentrifuge for 5 min and resuspended in 500 µl freshly prepared
PBS-BSA (0.04%). Samples were then sonicated with a Fisher Model 50 Sonic
Dismembrator at 3.5 W for 10 s to disperse clumps and separate cyto-kinesed buds. To
stain actin for immunofluorescent visualization, cells were pelleted, resuspended in 12 µl
PBS-BSA and 6 µl rhodamine-phalloidine (Molecular Probes) and incubated in the dark
for 30 min at room temperature. Samples were then pelleted and resuspended three times
in 25 µl PBS-BSA. After the final wash, pellet was resuspended in 30 µl PBS-BSA. 10 µl
of each sample was prepared as a wet-mount slide and viewed under a Texas red filter set
using a Leica DM5500B microscope with a Q-Imaging Retiga Exi 1394 Fast camera.

YopT Immunofluorescence
Samples were fixed as described above. Cells were spheroplasted and stained as
described previously by Nejedlik et al. (148). Mounting solution prepared following
protocol outlined by Pringle et al. (168). Samples were viewed under a FITC filter for
YopT and a DAPI filter for DNA using a Leica DM5500B microscope with a Q-Imaging
Retiga Exi 1394 Fast camera.

Two-hybrid Plasmid Construction
The GATEWAY™ LR reaction (lnvitrogen) was utilized to create the YopT bait
plasmid, pPC1. This was done by transferring YopT from the entry clone pJG487 to the
destination vector pLN2. Confirmation of bait construct was done by comparing EcoRI
digestion of pLN2 destination vector and pPC1.
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As the known in vivo and in vitro targets are members of the RhoGTPase family,
prey plasmids carrying yeast RhoGTPase homologs were constructed as controls. The
rhol-5 and cdc42 genes were PCR amplified using PfuUltra™ High-Fidelity DNA
Polymerase (Stratgene®). Primers used were as follows: rho] forward (5'
GCAGCTCCATGGCACAACAAGTTGGTAACA-3') containing an Ncol site
and reverse (5'-GCAGCTGGATCCCTATAACAAGACACACTTCTT-3') containing a
BamHI site, rho2 forward (5'-GCAGCTCCATGGCTGAAAAGGCCGTTAG-3')
containing an Ncol site and reverse (5'-

GCAGCTGGATCCTTATAAAATTATGCAACAGTTAGC-3') containing an BamHI
site, rho3 forward (5'-GCAGCTCCATGGCATTTCTATGTGGGTCAG-3') containing
an Ncol site and reverse (5'-GCAGCTGAATTCTTACATAATGGTACAGCTG-3')
containing an EcoRI site, rho4 forward (5'GCAGCTCCATGGATACACTATTATTTAAGCGA-3') containing an Ncol site and
reverse (5'-GCAGCTGGATCCTTACATTATAATACACTTGTT-3') containing an
BamHI site, rho5 forward (5'-GCAGCTCCATGGGGTCTATTAAATGTGTGAT-3')
containing an Ncol site and reverse (5'
GCAGCTGGATCCTTAAAGTATTACACACTTTG-3') containing an BamHI site,
cdc42 forward (5'-GCAGCTCCATGGAAACGCTAAAGTGTGTTG-3') containing an
Ncol site and reverse (5'-GCAGCTGGATCCCTACAAAATTGCACATTTTTTAC-3')
containing an BamHI site. Samples were purified with the QIAquick® PCR Purification
Kit. PCR products were cloned into the pCR®-Blunt 11-TOPO® vector and then
transformed into One Shot® chemically competent E. coli. Plasmid containing colonies
were selected for on LB+Kanamycin plates. Liquid LB+Kan was inoculated with plasmid
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containing E. coli and allowed to grow overnight at 37 ° C. Plasmid DNA was extracted
using the alkaline lysis minipreparation as described by Maniatis (132).
Next, the RhoGTPase genes were transferred into the pACII vector. The
RhoGTPase-pCR®-Blunt 11-TOPO® and pACTII plasmids underwent double digests with
Ncol and BamHI (Ncol/EcoRI for RHO3) and samples were run on a 1% agarose gel.
This process linearizes the vectors and releases the RhoGTPase genes. Desired DNA
bands (Rhos and pACII) were excised with a razor blade, placed in a microfuge tube, and
frozen. DNA was eluted using the QIAEX II Agarose Gel Extraction protocol.
RhoGTPases were ligated into the pACII vector by mixing 1 µl each T4 DNA Ligase and
lOx T4 DNA Ligase Buffer (New England Biolabs, Inc.), 1 µl ATP, 2 µl pACII vector,
and 5 µl RhoGTPase DNA. Mixture was incubated overnight in a 16 ° C water bath.
RhoGTPase-pACII ligation was transformed in to chemically competent DH5a E. coli.
10 µl of ligation plus 100 µl of DH5a cells was incubated on ice for 30 min then heat
shocked for 45 sec at 37 ° C. 1 ml of LB broth was added and culture was incubated at
37 ° C for one hour. Culture was plated on LB+Ampicillin to select for plasmid
containing cells. Liquid LB+Arnp was inoculated with plasmid containing E. coli and
allowed to grow overnight at 37 ° C. Plasmid DNA was extracted using the alkaline lysis
minipreparation as described by Maniatis (132). Prey plasmids construct was verified via
double digests with Ncol and BamHI (Ncol/EcoRI for RHO3) with samples run on a 1%
agarose gel.

Yeast Two-hybrid Screen
YopT bait plasmid pPCl was transformed into JGY80 yeast. 80+pPC1
transformants were plated on SD-trp and allowed to form colonies. Yeast genomic
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libraries (YL2H-Cl , C2, or C3) were then transformed into 80+pPCl . Transformants
were plated on SD-trp-leu-his plates. When colonies had formed, implying interaction
and transcriptional activation of histidine reporter gene, plates were replica plated using
an aluminum replica block, plate collar, and sterilized velveteen (Cora Styles Needles 'N
Blocks) onto SD-trp-leu-ade plates. Colonies that grew on second reporter plate were
picked and streaked on SD-trp-leu plate. Efficiency plates for each transformation were
performed: serial dilutions were plated on SD-trp-leu to select for yeast containing bait
and prey plasmids and determine the efficiency of the transformation. Streaks were then
resuspended 200 µl H2O and, using a microtiter well plate and inoculating frogger (Dan
Kar Corporation), were replica plated onto SD-trp-leu, SD-trp-leu-his, and SD-trp-leu
ade.
DNA from those that grew on all three plates was extracted via GuHCl yeast
genomic DNA preparation. Isolated DNA was transformed into XL I-Blue
electrocompetent E. coli via electroporation using a Bio-Rad MicroPulser™ following
the manufacturer's instructions (Bio-Rad Laboratories) and plated on LB+Ampicillin.
Liquid LB+Amp was inoculated with plasmid containing E. coli and allowed to grow
overnight at 37 ° C. Plasmid DNA was extracted using the alkaline lysis minipreparation
as described by Maniatis (132).
YopT bait plasmid pPCl was freshly transformed into JGY80 yeast. 80+pPC1
transformants were plated on SD-trp and allowed to form colonies. Yeast genomic library
plasmids were then transformed into 80+pPC1. Transformants were plated on SD-trp-leu
plates. Single colonies were picked and streaked on SD-trp-leu plates. Streaks were
resuspended 200 µl H2O and, using a microtiter well plate and inoculating frogger (Dan-
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Kar Corporation), were replica plated onto SD-trp-leu, SD-trp-leu-his, and SD-trp-leu
ade.

IV. Results and Discussion
Expression of YopT is Lethal to Yeast
To determine whether Saccharomyces cerevisiae was a suitable model to study
YopT cytotoxicity, we tested whether expression of YopT was lethal when expressed in
this organism. Previous work has shown that YopT from Yersinia pestis is lethal when
expressed in yeast (176). The expression vector used in that study was based upon
previously published inducible plasmids (145, 146). Our lab has created a series of
galactose-inducible, centromere-based yeast expression vectors that take advantage of
CEN6-ARSH4

CEN6-ARSH4

pJG485

pJG495
f1

f1

Xhol

Xhol

Clal

Clal

Sall

Hindlll
EcoRI
(Smal)

ori

Sall

Hindlll
EcoRI
(Smal)

ori
(Sacl)

att81

attR1

Figure I - Empty vector control (left) and YopT expression vector (right).

Gateway® technology (lnvitrogen) to quickly shuffle cloned genes between vectors (79,
148). Previous work showed the Yersinia enterocolitica T3 S effector YopO could be
expressed in and was cytotoxic to yeast (148). Using a similar construct, we examined
whether expression of YopT was lethal to yeast. Our yeast expression vector, pJG495,
contains the yopT gene cloned from Yersinia enterocolitica. The yopT gene is under
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control of the GALI promoter allowing for inducible expression. A 6xHis tag is available
for purification and a VS epitope is present for localization. An empty vector control
plasmid, pJG485, lacking yopT, but retaining all other plasmid sequences was also used.
These are autonomously replicating vectors containing a CEN6-ARSH4 sequence that
ensures low copy numbers, stability, and correct segregation during cell division. Both
pJG485 and pJG495 contained the URA3 auxotrophic marker for selection (Figure 1).
Yeast strain JGY709 was transformed with either pJG485 (empty vector control)
or pJG495 (YopT expression vector). Transformants were propagated in liquid synthetic
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Figure 2 - YopT-induced lethality in yeast. The dashed line indicates galactose induction immediately
after hour O sampling.

uracil-deficient medium containing 2% raffinose. The GAL 1 promoter is activated by the
presence of galactose, but actively suppressed in the presence of glucose. Raffinose
provides a "neutral" carbon source, neither suppressing nor activating the promoter, so
that upon induction, transcription of YopT is immediate. Aliquots were taken pre- and
post-galactose induction for titer growth assay, cell count, and cell cycle determination.
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The yeast containing the empty vector control plasmid, pJG485, showed a steady increase
of colony forming units, more than doubling over the course of the four hours (Figure 2).
The doubling time is in close agreement with the native growth rate of JGY709 yeast
(data not shown). In contrast, the yeast containing the YopT expression vector, pJG495,
exhibited a sharp decrease in viable cells. After one hour, less than half (42%) of cells
were still able to form colonies (Figure 2, Table 1). By hours 3 and 4 this had dropped to
5% and 1% respectively (Figure 2, Table 1). We therefore conclude that YopT expression
is lethal to yeast and provides a viable model system in which to examine this lethality.

Suppressors
In order to identify yeast genes involved in processes affected by YopT activity,
we generated spontaneous mutant suppressor lines. As we are looking for yeast that
survive YopT-induced lethality, we wanted to ensure that the observed phenotype was
% Change OfTiter (cfu/ml)
Ye ast Strain (Vector)
Hour0

HourI

Hour2

Hour3

Hour4

JGY709 (EV )

0

32

75

108

126

PCYI (YopT)

0

10

36

94

173

PCY2 (YopT)

0

38

108

154

204

PCY3 (YopT)

0

20

45

128

177

JGY709 (YopT)

0

-58

-86

-95

-99

Table 1 - Percent change of viable cells per ml from initial, pre-induction
sampling in growth titer assay.

due to a yeast mutation and not a single defective expression vector. Diploid yeast
JGY709 were transformed with two YopT expression vectors, pJG495 and pJG494, with
unique auxotrophic markers, URA3 and LEU2 respectively. Individual colonies were
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grown in liquid synthetic -ura-leu media containing 2% raffinose and plated on solid
media containing galactose. Colonies that formed were deemed potential suppressors.
Potential suppressors were forced to lose both plasmids and re-transformed with YopT
expressing vectors to confirm suppressing phenotype. We generated three suppressor
lines named PCYl, PCY2, and PCY3. Spontaneous mutations in yeast have previously
been characterized using the yeast centromere based plasmid-borne SUP4-o allele, the
URA3 gene integrated at the HIS3 locus, and the endogenous CAN] gene (122). Our
mutation rates are in agreement with those previously described (data not shown).
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Figure 3 - Growth titer assay comparing suppressor yeast (PCY 1-3) with wild type (JGY709). The
dashed line indicates galactose induction immediately after hour O sampling.

Once isolated, we wanted to compare suppressor (PCY1-3) growth with that of
wild type (JGY709). Growth titer assays were performed as described above using
diploid, YopT-expressing PCYl-3. Growth rates for YopT-expressing yeast are
comparable to the WT empty vector control (Figure 3). They show a steady increase in
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viable cells over the four hours, and exhibit faster growth rates than that of the EV
control.

Suppressor Specificity
In addition to YopT, both YopO and YopE have roles in disrupting the actin
cytoskeleton. In order to determine specificity of suppression, we also expressed YopO
and YopE in PCYl-3. In addition to the pJG495 (YopT) vector described above, pLNS
(YopO) and pJG491 (YopE) were utilized (with the exception of the Yop protein
expressed, the three plasmids are identical). Wild type (JG709) and suppressor (PCYl-3)

+
YPD

EV

YopO

YopT

WT

(

A

WT

PCY1

A

\(

PCY2 PCY3

WT

PCY1

YopE

\(

PCY2 PCY3

WT

A

PCY1

'

PCY2 PCY3

Media

Selects For

YPD

No selection

SD-ura

Plasmid containing

Sgal-ura

Plasrrid containing/Surviving YopT lethality

Figure 4 - Specificity of generated suppressor lines. When Yop expression vectors are induced by
plating on solid Sgal -ura media, only WT yeast (JGY709) exhibit growth deficiency.

yeast were transformed with each of the vectors. Wild type JGY709 containing the
pJG485 empty vector was used as a negative control. All three lines are shown to survive
expression of the three actin affecting Yops (Figure 4). Trans formants were plated on
YPD (no selection), SD-ura (selects for plasmid), and Sgal-ura (selects for plasmid and
suppression). All three suppressors (PCYl-3) are shown to survive expression of the
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actin affecting Yops with only wild type (JG709) yeast exhibiting deficiency in growth
(Figure 4).

YopT Localization
We examined cellular localization ofYopT in diploid suppressor (PCYl-3) and
WT (JGY709) yeast strains. We chose hour 3 after galactose induction to examine cells,
because our titer assays show hour three as having sufficient viable YopT-expressing WT
yeast to examine, while retaining a strong cytotoxic phenotype (Figure 3). DNA was
visualized via DAPI (4'-6-Diamidino-2-phenylindole), which forms fluorescent
complexes with double-stranded DNA. The YopT protein was visualized via the VS
epitope and a mouse anti-VS 1 ° antibody. The 2° antibody was goat anti-mouse
WT+EV

PCY1+YopT

PCY2+YopT

PCY3+YopT

WT+YopT

1 °/2 ° Ab+ Dapi

1 °/2 ° Ab+ Dapi
(Color Overlay)

-/2 ° Ab+ Dapi
(Color Overlay)

Figure 5 - YopT localization, three hours post-induction. YopT is stained green, DNA is stained blue.

conjugated to Cy2, a green fluorescing cyanine.
Diploid WT (JGY709) yeast containing the empty vector was used as a control.
To ensure that antibody staining was specific for our YopT construct, we performed
antibody staining with only the flour-conjugated 2 ° antibody. When expressed in WT
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(JGY709) yeast,YopT appears to localize at the outer edges of the cell (Figure 5). This is
consistent with its known membrane bound RhoGTPase target. In contrast,YopT was
found to be diffuse throughout the cell when expressed in suppressor yeast PCYl,PCY2,
and PCY3.
As described in our procedure for generating suppressors,we have taken care to
ensure the resultant phenotype is due to a mutation in the yeast genome and not the
expression vector. If the diffusion of our expressed YopT protein is indeed due to a yeast
mutation,what might be the nature of the mutation? The expressed protein seems to be
unable to interact with a target. The yeast could be doing something that affects the
transcription or translation of YopT,and thus the final gene product. YopT requires an
isoprenoid group for binding and activity upon its target. Something may be blocking
access to the recognition site of YopT' s target. Another possibility is that an alternative
lipid anchor,such as a palmitoylation,myristoylation,or glycosylphosphatidylinisotol
(GPI) anchor,could have been substituted for the isoprenoid that usually serves as a
membrane anchor for RhoGTPases.

Actin Localization
YopT has been shown to be cytotoxic to eukaryotic cells. The morphology
associated with this cytotoxicity is disruption of the actin cytoskeleton and subsequent
rounding up of the cells (7,107,176,182,207). In budding wild type yeast,actin appears
as cytoplasmic cables stretching along the mother-daughter axis and as cortical patches
that tend aggregate in regions of cell growth (144). Rhodamine-phalloidine,a phallotoxin
conjugated to the orange-fluorescent dye tetramethylrhodamine (TRITC) and with a high
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affinity for filamentous actin, was used to stain the F-actin ofWT yeast (JGY709)
containing the empty vector control (pJG485) in addition to JGY709 and suppressor yeast
PCYl, PCY2, and PCY3 containing a YopT expressing plasmid (pJG495). Cells were
examined immediately prior to galactose induction ofYopT and three hours post
induction (Figure 6).
At hour 0, immediately prior to galactose induction ofYopT, both cortical and

PCY1+YopT

PCY2+Yo T PCY3+YopT

HourO

Hour3

Figure 6 - Actin localization at hour O (pre-YopT induction) and hour 3 post-induction.

filamentous actin is present in all sampled yeast (Figure 6). At hour 3, our WT yeast
(JGY709) containing the empty vector control (pJG485) and the three YopT suppressor
strains (PCYl-3) expressing YopT (pJG495) exhibit a similar phenotype to hour O; there
is no evident disruption ofactin or cell rounding (Figure 6).
When fixing and staining cells, we endeavored to use the same approximate
concentration for each sample, about 108 cells/ml. Although we are examining the same
approximate number ofcells, when observing WT yeast (JGY709) expressing YopT
(pJG495) at hour three, the actual amount ofviable, visibly stained cells present is quite
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small, in accordance with our growth titer assay (Figure 3, Table 1). Interestingly, those
WT yeast (JGY709) expressing YopT (pJG495) that are still viable at hour 3 also exhibits
a pre-induction phenotype (Figure 6). Cortical patches are evident at the bud neck and in
the growing daughter cell and actin cables are present. There is some minor rounding
evident, as well as evidence of some actin cables extending not along the mother
daughter axis, but transversely within the mother cell. However, we observe none of the
striking actin disruption previously reported. Based on our growth titer assays, it is
evident that YopT has a dynamic effect on WT yeast viability (Figure 3, Table 1 ). Given
the rapid lethality of YopT when expressed in yeast, we feel that a more prudent
approach in the future would be to track actin at short, regular intervals from pre
induction to three hours post-induction. This would presumably give us a more accurate
view of the dynamic effects of YopT upon the yeast cytoskeleton.

Yeast Two-hybrid Screen
In an effort to identify cellular targets of YopT, we performed a yeast two-hybrid
screen. The two-hybrid system screens for the interaction of two proteins, which are
a/IL

CroflT7

+

entry clone
(pJG487)

a/IP

ccdB

by-product

allR

a/IL

a/IP

•
+

ccd87

ullR

destination vector
(pLN2)

at1B

L);:'.op1

ullB

expression vector
(pPCI)

Figure 7 - Gateway® LR Reaction. Sequences can be exchanged between
vectors via the alt recombination sites.

41

expressed as fusion proteins. One is fused to a DNA-binding domain (the "bait") while
the other is fused to a transcriptional activation domain (the "prey"). These chimeric
proteins are co-expressed in yeast where a physical interaction between the two
reconstitutes the functional transcription factor, activating a reporter gene.
In order to create a bait plasmid we exploited Gateway® technology (Invitrogen)
to exchange genes between vectors. The yopT gene was transferred from the entry clone

Figure 8 - EcoRI digest
of Gateway® LR reaction
destination vector (pLN2)
and resultant expression
vector (pPCl). Lambda
DNA-Hind III molecular
weight ladder is located in
the left lane.

pJG487 to the destination vector pLN2 to create the two-hybrid bait plasmid, pPCl
(Figure 7). To confirm successful gene transfer and vector construct, we compared
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restriction digest profiles of the original destination vector (pLN2) and the final
expression vector (pPCl). Utilizing an EcoRI digest and agarose gel electrophoresis, we
see an expected three fragments for both plasmids, with an increase of the smallest band
from ~500 bp in pLN2 to ~ 1000 bp in pPC1 (Figure 8). The fourth band in the pPC1 lane
is an incomplete cut between two of the fragments.
The bait plasmid containing a YopT-DNA binding domain fusion and Y2HL
library prey plasmids in multiple reading frames (Cl, C2, & C3) were co-transformed
into yeast. To screen the Y2HL libraries at a 95% confidence level, ~860,000 clones must
be screened from each of the three libraries; 99% confidence requires ~1,325,000
Two-hybrid Library

Transformants
Potential interactions

Cl
3,909,600
82

C2
202,400
2

I

I

C3
1,150,400
45

Table 2 - List oftotal number oftransformants for each reading frame of the yeast two-hybrid library.

Below transformants is the number of primary, positive interactions observed.

transformants for each library (71). During our screening, we ran transformation
efficiency plates and required at least 1,000,000 transformants for each library to consider
it fully screened. Library Cl had 3,909,600 transformants with 82 potential interactions,
C2 had 202,400 with 2 potential interactions, and C3 had 1,150,400 with 45 potential
interactions (Table 2). Interactions were determined via growth on reporter deficient
media; either -his or -ade.
The two-hybrid system has a number of advantages: i) it is an in vivo process, ii)
it can detect transient or unstable interactions, iii) it has high fidelity, allowing for
interaction mapping between the proteins, and iv) it is independent of endogenous protein
expression (194). However, it possesses drawbacks as well: it takes place within the
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nucleus where interactions may not reflect a native physiological interaction and it has a
propensity for false positives. Some false positives may be caused by bait plasmids that
act as transcriptional activators, others may be the result of non-specific interactions. In
order to minimize false positives, library plasmids were isolated from potential
interactions, retransformed into yeast containing YopT bait plasmids, and plated again on
reporter deficient media. A third reporter, the Lacz gene, was also employed.
Interactions that passed the second screen were sequenced. The bulk of these hits
were ribosomal subunit proteins. Also pulled out of the screen were the genes SW/4 and
TIF5. SW/4 encodes the protein Swi4, which forms a heterodimer with Swi6 to produce
the transcription factor SBF (SCB binding factor) (18). Swi4 remains nuclear located
throughout the cell cycle (17). TIF5 encodes eIF5 (eukaryotic translation initiation factor
5), a monomeric protein that acts as a GTPase-activating protein (GAP) in eukaryotic
translation initiation. It promotes hydrolysis of the 43s pre-initiation complex, releasing
eIF2-GDP (and Pi) as well as eIF3 from the 40s ribosomal subunit, allowing the 40s and
60s subunits to form a functional 80s initiation complex (58).
The Golemis lab at the Fox Chase Cancer Center maintains a database of
commonly reported false positives (83). Among the commonly reported false positives
are ribosomal proteins, transcription factors, and elongation factors. These categories
encompass the identified interactions from our screen. In addition, SWI4 remains native
to the nucleus, a compartment where YopT is not known to localize. Additional �
galactosidase assays were performed to test for Lacz reporter product, but were negative
for enzyme activity (data not shown). As such, we believe that these interactions are
physiologically irrelevant to YopT' s activity in yeast.
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Yeast Two-hybrid Positive Controls
Due to the dearth of relevant interaction isolated from the yeast library screen, we
constructed prey plasmids containing the six yeast RhoGTPase homologs (Cdc42, Rho15) for use as positive controls. The six genes were PCR amplified and subsequently
inserted into prey two-hybrid expression vectors. When tested, none of these revealed
interaction with YopT.
In order to localize to the cell membrane, RhoGTPases undergo ordered
posttranslational modifications at their C-terminal CaaX box in which the C-terminal
cysteine is prenylated, the -aaX motif is removed, and the cysteine is carboxylmethylated
(73, 204). YopT's substrate specificity is determined by the presence of this isoprenoid
lipid modification and a sequence of basic amino acids at the C-terminal of RhoGTPases
(177). Our results may be explained by the lack of the posttranslational modification of
RhoGTPases that serves as a recognition element for YopT. Previous reports have shown
that GST (Glutathione S-Transferase) pull-down assays using YopT and RhoGTPases
produced in bacteria (which are incapable of posttranslationally modifying GTPase)
exhibit no interaction. A further explanation for our result may rest in the fact that two
hybrid interactions must take place within the nucleus. If the bait and prey proteins do not
localize to the nucleus, no reporter product will be produced, regardless of whether they
are interacting or not. At this time, we feel that we exhausted the two-hybrid analysis as a
tool for looking at YopT and therefore we have not completed the C2 screen (Table 2).
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